TCL Archive Accrual Picking Up, Still “Nothing To Write Home About;” Unfunded MDs ‘Subsidizing Entire Program” June 3, 1988
TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006
TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010
TCL Archive NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation June 12, 1992
